| 13646-5 |
Methaqualone |
MCnt |
Hair |
Pt |
Qn |
|
|
ACTIVE |
Methaqualone [Mass/mass] in Hair |
|
MIN |
DefinitionDescription |
|
|
ng/g |
|
|
|
|
|
|
DRUG/TOX |
|
13646-5 |
|
|
|
|
Both |
|
|
|
0 |
Methaqualone Hair-mCnt |
|
|
|
Y |
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Mass Content; Methaqualon; Point in time; PotentialForAbuse; QNT; Quaalude; Quan; Quant; Quantitative; Random |
2.7 |
1.0k |
|
|
|
|
|
|
|
ng/g |
|
|
|
0 |
| 13647-3 |
Methylene chloride |
MCnc |
Bld |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Methylene chloride [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13647-3 |
|
|
|
|
|
|
|
|
0 |
Deprecated DCM Bld-mCnc |
|
|
|
Y |
|
Addiction; Blood; Cl; Cl-; DCM; Dichloromethane; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.7 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 13648-1 |
Morphine |
PrThr |
Urine |
Pt |
Ord |
SAMHSA confirm |
|
ACTIVE |
Morphine [Presence] in Urine by SAMHSA confirm method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
13648-1 |
|
SAMHSA confirm |
|
|
Both |
|
|
|
0 |
Morphine Ur Ql SAMHSA Cfm |
|
|
|
|
|
Addiction; c260; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Morphine sulfate; MS; MSO4; OMPH; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; SAMHSA Cfm; SAMSHA; Screen; Substance Abuse and Mental Health Services Administration; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 13649-9 |
Nickel |
MCnc |
Water |
Pt |
Qn |
|
|
ACTIVE |
Nickel [Mass/volume] in Water |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
13649-9 |
|
|
|
|
Both |
|
|
|
0 |
Nickel Wat-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; NI; Point in time; QNT; Quan; Quant; Quantitative; Random; Wat |
2.7 |
1.0k |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 1365-6 |
Corticotropin^45M post dose insulin IV |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Corticotropin [Mass/volume] in Plasma --45 minutes post dose insulin IV |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ng/L |
|
|
|
|
|
|
CHAL |
|
1365-6 |
|
|
|
|
Observation |
|
|
|
0 |
ACTH 45M p Ins IV Plas-mCnc |
|
|
|
Y |
|
45M p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Tumor marker; Ultralente |
2.4 |
1 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 13650-7 |
1,2-Dimethylbenzene |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
1,2-Dimethylbenzene [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13650-7 |
|
|
|
|
Both |
|
|
|
0 |
1,2DMB Bld-mCnc |
|
|
|
Y |
|
1,2DMB; Blood; Dmb; DRUG/TOXICOLOGY; Drugs; i; II; Level; Mass concentration; Orthoxylene; Ortho-xylene; O-xylene; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood; Xylene; Xylol |
2.73 |
1.0k |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 13651-5 |
1,4-Dimethylbenzene |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
1,4-Dimethylbenzene [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13651-5 |
|
|
|
|
Both |
|
|
|
0 |
1,4DMB Bld-mCnc |
|
|
|
Y |
|
1,4DMB; Addiction; Blood; Dmb; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; i; Illicit; Level; Mass concentration; Para-xylene; Point in time; PotentialForAbuse; p-xylene; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood; Xylene; Xylol |
2.73 |
1.0k |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 13652-3 |
Zinc |
MCnt |
Hair |
Pt |
Qn |
|
|
ACTIVE |
Zinc [Mass/mass] in Hair |
|
MIN |
DefinitionDescription |
|
|
ug/g |
|
|
|
|
|
|
DRUG/TOX |
|
13652-3 |
|
|
|
|
Both |
|
|
|
0 |
Zinc Hair-mCnt |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Har; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Zn |
2.73 |
1.0k |
|
|
|
|
|
|
|
ug/g |
|
|
|
0 |
| 13653-1 |
Epithelial cells.renal |
NCnc |
Urine sed |
Pt |
Qn |
|
|
ACTIVE |
Epithelial cells.renal [#/volume] in Urine sediment |
|
MIN |
DefinitionDescription |
|
|
/mL |
|
|
|
|
|
|
UA |
|
13653-1 |
|
|
|
|
Observation |
|
|
|
0 |
Renal Epi Cells # UrnS |
|
|
|
Y |
|
#; ABS; absolute; absolutes; Cell; Cellularity; Cnt; Count; Count/volume; CT; Epi; Epi Cells; Epith; Epithelia; Kidney; Kidney cells; Nephrology; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; REC; Renal; Renal Epi Cells; Renal tubular cells; RTC; RTE; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.73 |
1.0k |
|
|
|
|
|
|
|
/mL |
|
|
|
0 |
| 13654-9 |
Epithelial cells.squamous |
NCnc |
Urine sed |
Pt |
Qn |
|
|
ACTIVE |
Epithelial cells.squamous [#/volume] in Urine sediment |
|
MIN |
DefinitionDescription |
|
|
/mL |
|
|
|
|
|
|
UA |
|
13654-9 |
|
|
|
|
Observation |
|
|
|
0 |
Squamous # UrnS |
|
|
|
Y |
|
#; ABS; absolute; absolutes; Cell; Cellularity; Cnt; Count; Count/volume; CT; Epi; Epi Cells; Epith; Epithelia; Kidney; Nephrology; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SEC; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.73 |
1.0k |
|
|
|
|
|
|
|
/mL |
|
|
|
0 |
| 13655-6 |
Leukocytes |
PrThr |
Stool |
Pt |
Ord |
Microscopy.light |
|
ACTIVE |
Leukocytes [Presence] in Stool by Light microscopy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
13655-6 |
|
Microscopy.light |
|
|
Both |
|
|
|
0 |
WBC Stl Ql Micro |
|
|
|
|
|
Bowel movement; Faecal; Faeces; Fecal; Feces; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; UniversalLabOrders; WBC; WBCs; White blood cell; White blood cells |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
144 |
| 13656-4 |
Phosphate crystals.amorphous |
NCnc |
Urine sed |
Pt |
Qn |
|
|
ACTIVE |
Phosphate crystals amorphous [#/volume] in Urine sediment |
|
MIN |
DefinitionDescription |
|
|
/mL |
|
|
|
|
|
|
UA |
|
13656-4 |
|
|
|
|
Observation |
|
|
|
0 |
Amorph Phos Cry # UrnS |
|
|
|
Y |
|
#; ABS; absolute; absolutes; AM; Amorph; Amorph Cry; Amorph Phos Cry; Amorphic; Cnt; Count; Count/volume; Crys; Cryst; Crystal; CT; i Phos; Inorganic phosphate; Kidney; Nephrology; Number concentration; Number Concentration (count/vol); Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.73 |
1.0k |
|
|
|
|
|
|
|
/mL |
|
|
|
0 |
| 13657-2 |
Urate crystals.amorphous |
NCnc |
Urine sed |
Pt |
Qn |
|
|
ACTIVE |
Urate crystals amorphous [#/volume] in Urine sediment |
|
MIN |
DefinitionDescription |
|
|
/mL |
|
|
|
|
|
|
UA |
|
13657-2 |
|
|
|
|
Observation |
|
|
|
0 |
Amorph Urate Cry # UrnS |
|
|
|
Y |
|
#; ABS; absolute; absolutes; AM; Amorph; Amorph Cry; Amorph Urate Cry; Amorphic; Cnt; Count; Count/volume; Crys; Cryst; Crystal; CT; Kidney; Nephrology; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; Urates; Uric acid; URINALYSIS; Urine sediment; Urn; UrnS |
2.73 |
1.0k |
|
|
|
|
|
|
|
/mL |
|
|
|
0 |
| 13658-0 |
Urobilinogen |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Urobilinogen [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
13658-0 |
|
|
|
|
Both |
|
|
|
0 |
Urobilinogen Ur Ql |
|
|
|
|
|
Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UBG; UR; Urn; Urobili; Urobilngn |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 13659-8 |
Epidermal growth factor receptor |
MCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Epidermal growth factor receptor [Mass/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
ng/g |
|
|
|
|
|
|
PATH |
|
13659-8 |
|
|
|
|
Both |
|
|
|
0 |
EGFR Tiss-mCnt |
|
|
|
Y |
|
EGF; EGFR; Fac; Fact; HER1; Mass content; Oncology; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Tissue; Tissue, unspecified |
2.7 |
1.0k |
|
|
|
|
|
|
|
ng/g |
|
|
|
0 |
| 1366-4 |
Corticotropin^5M post 1 ug/kg CRH IV |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Corticotropin [Mass/volume] in Plasma --5 minutes post 1 ug/kg CRH IV |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ng/L |
|
|
|
|
|
|
CHAL |
|
1366-4 |
|
|
|
|
Observation |
|
|
|
0 |
ACTH 5M p 1 ug/kg CRH IV Plas-mCnc |
|
|
|
Y |
|
5M p 1 ug/kg CRH IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; i; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker |
2.4 |
1 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 13660-6 |
Gonadotropin releasing hormone |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Gonadotropin releasing hormone [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
13660-6 |
|
|
|
|
Both |
|
|
|
0 |
GnRH SerPl-mCnc |
|
|
|
Y |
|
Chemistry; Endocrine; Endocrinology; GHR; GnRH; Horm; Level; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 13661-4 |
Ganglioside GD1b Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Ganglioside GD1b IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
13661-4 |
|
|
|
|
Observation |
|
|
|
0 |
GD1b Gangl IgM Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Disialolganglioside; Disialylganglioside; GD1b; GD1b Gangl; Immune globulin M; Immunoglobulin M; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 13662-2 |
Ganglioside GD1b Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Ganglioside GD1b IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
13662-2 |
|
|
|
|
Observation |
|
|
|
0 |
GD1b Gangl IgG Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Disialolganglioside; Disialylganglioside; GD1b; GD1b Gangl; Immune globulin G; Immunoglobulin G; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 13663-0 |
Asialoganglioside GM1 Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Asialoganglioside GM1 IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
13663-0 |
|
|
|
|
Observation |
|
|
|
0 |
GM1 Asialo IgG Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Asialo Gm1; AsialoGM1; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Ganglioside asialo; GM1 Asialo; Immune globulin G; Immunoglobulin G; Monoasialoganglioside; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 13664-8 |
Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
13664-8 |
|
|
|
|
Both |
|
|
|
0 |
MAG/SGPG IgM Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); gG; Glycoprot; Glycoproteins; GP; Immune globulin M; Immunoglobulin M; MAG; MAG/SGPG; MAGM; MAG-SGPG; Point in time; Random; Serology; Serum; SGPG.IGM; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 13665-5 |
1-Methylhistidine/Creatinine |
MRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
1-Methylhistidine/Creatinine [Mass Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
mg/g creatinine |
|
|
|
|
|
|
CHEM |
|
13665-5 |
|
|
|
|
Observation |
|
|
|
0 |
1Me-hist/Creat Ur |
|
|
|
Y |
|
1Me-hist; Chemistry; CR; Crea; Creat; i; Mass concentration ratio; Mass ratio; MCRto; methyl-histidine; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
mg/g{creat} |
|
|
|
0 |
| 13666-3 |
Alpha aminoadipate/Creatinine |
MRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Alpha aminoadipate/Creatinine [Mass Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
mg/g creatinine |
|
|
|
|
|
|
CHEM |
|
13666-3 |
|
|
|
|
Observation |
|
|
|
0 |
AAA/Creat Ur |
|
|
|
Y |
|
2-aminoadipate; 2-aminoadipic acid; AAA; AAD; Alfa; Alpha aminoadipic acid; Aminoadipic acid; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
mg/g{creat} |
|
|
|
0 |
| 13667-1 |
Alpha aminobutyrate/Creatinine |
MRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Alpha aminobutyrate/Creatinine [Mass Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
mg/g creatinine |
|
|
|
|
|
|
CHEM |
|
13667-1 |
|
|
|
|
Observation |
|
|
|
0 |
A-Aminobutyr/Creat Ur |
|
|
|
Y |
|
2-aminobutanoic acid; 2-aminobutyrate; 2-aminobutyric acid; A-Aminobutyr; AANB; A-ANB; Alfa; Alpha aminobutyric acid; Alpha amino-n-butyrate; Alpha amino-n-butyric acid; Aminobutric; Aminobutyric; Amino-n-butyrate; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
mg/g{creat} |
|
|
|
0 |
| 13668-9 |
2-Ethylhydracrylate/Creatinine |
MRto |
Urine |
Pt |
Qn |
|
|
DISCOURAGED |
2-Ethylhydracrylate/Creatinine [Mass Ratio] in Urine |
|
NAM |
DefinitionDescription |
|
|
ug/g creatinine |
|
|
|
|
|
|
CHEM |
|
13668-9 |
|
|
|
|
Observation |
|
|
|
0 |
2-ethylhydracrylate/Creat Ur |
|
|
|
Y |
|
2-EHA; 2-Ethyl-3-Hydroxypropionate; 2-ethyl-3-hydroxypropionic acid; Chemistry; CR; Crea; Creat; Ethyl lactate; II; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn |
2.79 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
